VIDO-InterVac at the University of Saskatchewan. (Photo: Debra Marshall)

USask’s VIDO-InterVac and the National Research Council of Canada collaborate to advance development of vaccine against COVID-19

Posted on

Ce contenu n’est disponible qu’en anglais.

Key research and development organizations to leverage Canadian expertise and technologies in battle against COVID-19.

The University of Saskatchewan’s (USaskVaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) and the National Research Council of Canada (NRC) today announced a collaboration to work together to accelerate the development and production of a candidate COVID-19 antigen in mammalian cells…..
 

Read More Impact Stories

Posté le
Ce contenu n’est disponible qu’en anglais. https://reporter.mcgill.ca/covid-and-rsv-testing-without-nasal-swabs-yes-please/
Posté le
Les risques de séquelles psychologiques sont plus élevés dans certains groupes de la population, mais personne n’est tout à fait [...]
Posté le
Ce contenu n’est disponible qu’en anglais.   https://www.utoronto.ca/news/u-t-partners-moderna-advance-research-rna-science-and-technology